Scrip
Forest hit by US product delays
10 March 2009
Katie McQue
Please Login to read the full article.
10 March 2009
Katie McQue
Forest Laboratories has suffered setbacks to its pipeline after a meeting with the US
FDA prompted it to postpone its NDA for the COPD treatment aclidinium bromide, which is being developed under a partnership with
Almirall. On the same day, the company announced it was pushing back the US launch...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
